Improvement of the evaluation method for teratogenicity using zebrafish embryos

Journal of Toxicological Sciences

Volumn 39, Issue 3, 2014, Pages 453-464

  Yamashita, Akihito ^a   Inada, Hiroshi ^a   Chihara, Kazuhiro ^a   Yamada, Toru ^a   Deguchi, Jiro ^a   Funabashi, Hitoshi ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Screening; Teratogenicity; Zebrafish

Indexed keywords

ACETYLSALICYLIC ACID; BETAXOLOL; CYPROHEPTADINE; INDOMETACIN; RIBAVIRIN; SPARFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; EGG PRODUCTION; EMBRYO; FEMALE; MALE; NONHUMAN; ORGANOGENESIS; TERATOGENICITY; ZEBRA FISH;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; EMBRYO, NONMAMMALIAN; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HIGH-THROUGHPUT SCREENING ASSAYS; ORGANOGENESIS; TERATOGENESIS; TERATOGENS; TOXICITY TESTS; ZEBRAFISH;

EID: 84901300483     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.39.453     Document Type: Article

References (42)

1. Brannen, K.C., Panzica-Kelly, J.M., Danberry, T.L. and Augustine-Rauch, K.A. (2010): Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. Birth Defects Res. B Dev. Reprod. Toxicol., 89, 66-77.
2. Cook, J.C., Jacobson, C.F., Gao, F., Tassinari, M.S., Hurtt, M.E. and DeSesso, J.M. (2003): Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Birth Defects Res. B Dev. Reprod. Toxicol., 68, 5-26.
3. de Jong, E., Barenys, M., Hermsen, S.A., Verhoef, A., Ossendorp, B.C., Bessems, J.G. and Piersma, A.H. (2011): Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-triazoles. Toxicol. Appl. Pharmacol.,253, 103-111.
4. de la Fuente, M. and Alia, M. (1982): The teratogenicity of cyproheptadine in two generations of Wistar rats. Arch. Int. Pharmacodyn. Ther., 257, 168-176.
5. Dooley, K. and Zon, L.I. (2000): Zebrafish: a model system for the study of human disease. Curr. Opin. Genet. Dev., 10, 252-256.
6. Finn, J., Hui, M., Li, V., Lorenzi, V., de la Paz, N., Cheng, S.H., Lai-Chan, L. and Schlenk, D. (2012): Effects of propranolol on heart rate and development in Japanese medaka (Oryzias latipes) and zebrafish (Danio rerio). Aquat. Toxicol., 122-123, 214-221.
7. Flint, O.P. (1993): In vitro tests for teratogens: desirable endpoints, test batteries and current status of the micromass teratogen test. Reprod. Toxicol., 7 Suppl. 1, 103-111.
8. Funabashi, H., Mukumoto, K., Kunimatsu, S., Nishimura, K. and Onishi, K. (1991): Reproductive and developmental toxicity studies of sparfloxacin. (2). Teratogenicity study in rats. Yakuri to chiryo: Basic pharmacology & therapeutics, 19, 1257-1274.
9. Henn, K. and Braunbeck, T. (2011): Dechorionation as a tool to improve the fish embryo toxicity test (FET) with the zebrafish (Danio rerio). Comp. Biochem. Physiol. C Toxicol. Pharmacol.,153, 91-98.
10. Hill, A.J., Teraoka, H., Heideman, W. and Peterson, R.E. (2005): Zebrafish as a Model Vertebrate for Investigating Chemical Toxicity. Toxicol. Sci., 86, 6-19.
11. Homma, M., Matsuzaki, Y., Inoue, Y., Shibata, M., Mitamura, K., Tanaka, N. and Kohda, Y. (2004): Marked elevation of erythrocyte ribavirin levels in interferon and ribavirin-induced anemia. Clin. Gastroenterol. Hepatol., 2, 337-339.
12. Inoue, Y., Homma, M., Matsuzaki, Y., Shibata, M., Matsumura, T., Ito, T. and Kohda, Y. (2006): Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy. Hepatol. Res., 34, 23-27.
13. Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y. and Handa, H. (2010): Identification of a primary target of thalidomide teratogenicity. Science, 327, 1345-1350.
14. Johnson, E.M. (1990): Developmental toxicity and safety evaluations of ribavirin. Pediatr. Infect. Dis. J., 9, S85-87.
15. Kais, B., Schneider, K.E., Keiter, S., Henn, K., Ackermann, C. and Braunbeck, T. (2013): DMSO modifies the permeability of the zebrafish (Danio rerio) chorion-implications for the fish embryo test (FET). Aquat. Toxicol., 140-141, 229-238.
16. Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B. and Schilling, T.F. (1995): Stages of embryonic development of the zebrafish. Dev. Dyn., 203, 253-310.
17. Kochhar, D.M., Penner, J.D. and Knudsen, T.B. (1980): Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice. Toxicol. Appl. Pharmacol., 52, 99-112.
18. Koseki, N., Deguchi, J., Yamada, T., Funabashi, H. and Seki, T. (2010): Improvement of the embryonic stem cell test endpoint analysis by use of field potential detection. J. Toxicol. Sci.,35, 619-629.
19. Kozer, E., Nikfar, S., Costei, A., Boskovic, R., Nulman, I. and Koren, G. (2002): Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am. J. Obstet. Gynecol., 187, 1623-1630.
20. Kusayanagi, T., Ihara, T. and Mizutani, M. (1977): Teratogenic Effects of Non-steroidal Anti-inflammatory Agents in mice. Congenital Anomalies, 17, 9.
21. Martinez-Angoa, A., Parra-Hernandez, E., Madrigal-Bujaidar, E., Chamorro-Cevallos, G., Carvajal-Sandoval, G. and Zamudio-Cortes, P. (2006): Reduction of all-trans-retinoic acid-induced teratogenesis in the rat by glycine administration. Birth. Defects. Res. A Clin. Mol. Teratol.,76, 731-738.
22. Massarsky, A., Trudeau, V.L. and Moon, T.W. (2011): beta-blockers as endocrine disruptors: the potential effects of human beta-blockers on aquatic organisms. J. Exp. Zool. A Ecol. Genet. Physiol., 315, 251-265.
23. Menegola, E., Broccia, M.L., Nau, H., Prati, M., Ricolfi, R. and Giavini, E. (1996): Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratog Carcinog Mutagen, 16, 97-108.
24. Nagel, R. (2002): DarT: The embryo test with the Zebrafish Danio rerio--a general model in ecotoxicology and toxicology. Altex, 19 Suppl. 1, 38-48.
25. Ornoy, A. (2006): Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod. Toxicol., 22, 214-226.
26. Page, T. and Connor, J.D. (1990): The metabolism of ribavirin in erythrocytes and nucleated cells. Int. J. Biochem., 22, 379-383.
27. Panzica-Kelly, J.M., Zhang, C.X., Danberry, T.L., Flood, A., DeLan, J.W., Brannen, K.C. and Augustine-Rauch, K.A. (2010): Morphological score assignment guidelines for the dechorionated zebrafish teratogenicity assay. Birth Defects. Res. B Dev. Reprod. Toxicol., 89, 382-395.
28. Peters, A.K., Wouwer, G.V., Weyn, B., Verheyen, G.R., Vanparys, P. and Gompel, J.V. (2008): Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity. Toxicol In Vitro, 22, 1948-1956.
29. Risser, A., Donovan, D., Heintzman, J. and Page, T. (2009): NSAID prescribing precautions. Am. Fam. Physician., 80, 1371-1378.
30. Scholz, G., Genschow, E., Pohl, I., Bremer, S., Paparella, M., Raabe, H., Southee, J. and Spielmann, H. (1999): Prevalidation of the Embryonic Stem Cell Test (EST)-A New In vitro Embryotoxicity Test. Toxicol. In Vitro, 13, 675-681.
31. Selderslaghs, I.W., Blust, R. and Witters, H.E. (2012): Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. Reprod. Toxicol., 33, 142-154.
32. Selderslaghs, I.W., Van Rompay, A.R., De Coen, W. and Witters, H.E. (2009): Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod. Toxicol., 28, 308-320.
33. Shapiro, S., Siskind, V., Monson, R.R., Heinonen, O.P., Kaufman, D.W. and Slone, D. (1976): Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy. Lancet, 1, 1375-1376.
34. Street, J.A. and Walsh, A. (1984): Inhibition of synaptosomal [3H]noradrenaline uptake by beta-adrenoceptor blocking drugs: influence of lipophilicity. Eur. J. Pharmacol., 102, 315-324.
35. Sukardi, H., Chng, H.T., Chan, E.C., Gong, Z. and Lam, S.H. (2011): Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models. Expert. Opin. Drug Metab. Toxicol., 7, 579-589.
36. Sun, L., Xin, L., Peng, Z., Jin, R., Jin, Y., Qian, H. and Fu, Z. (2013): Toxicity and enantiospecific differences of two beta-blockers, propranolol and metoprolol, in the embryos and larvae of zebrafish (Danio rerio). Environ. Toxicol.
37. Suzuki, N., Ando, S., Yamashita, N., Horie, N. and Saito, K. (2011): Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro. Toxicol. Sci., 124, 460-471.
38. Tang, L.Q., Hong, P.H., Siddiqui, Y., Sarkissian, E.S., Huang, R.Y., Lee, E. and Krupin, T. (1998): Effect of beta-adrenergic agents on intracellular potential of rabbit ciliary epithelium. Curr. Eye. Res., 17, 24-30.
39. Tuchmann-Duplessis, H., Hiss, D., Mottot, G. and Rosner, I. (1975): Effects of prenatal administration of acetylsalicylic acid in rats. Toxicology, 3, 207-211.
40. Webster, W.S., Brown-Woodman, P.D. and Ritchie, H.E. (1997): A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing. Int. J. Dev. Biol., 41, 329-335.
41. Weinstein, D., Ornoy, A., Ben-Zur, Z., Pfeifer, Y. and Sulman, G.H. (1975): Teratogenicity of cyproheptadine in pregnant rats. Arch. Int. Pharmacodyn. Ther., 215, 345-349.
42. Zon, L.I. and Peterson, R.T. (2005): In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov., 4, 35-44.